Journey Colab
Ryan has 20 years’ experience conducting preclinical and clinical research supporting the development of a variety of CNS-active drugs, including over a decade working in the pharmaceutical, cannabinoid, and dietary supplement industries. He earned a doctorate in biological psychology from the University of North Carolina at Chapel Hill and completed a postdoctoral research fellowship at the Johns Hopkins University School of Medicine, Behavioral Pharmacology Research Unit.
This person is not in any offices
Journey Colab
Journey Colab is pursuing FDA approval of psychedelic therapies to heal individual mental health and strengthen communities. They plan to build a portfolio of plant-identical compounds. Their first compound in development is mescaline.